Asante-Viral Publishes Its 1st Trial Results

Asante-Viral, part of the Asante Philani Group of Companies, recently published the results of a 30-day trial of a new Health Supplement targeted at the HIV community. This new supplement can be taken with ARV’s and is suitable for people of all ages.

“If you are not taking ARV’s, this trial has shown dramatic reductions in viral loading and increased immune system support – two important markers in HIV research. In effect, this supplement from Asante-Viral operates the same way as a person’s immune cells,” reports Dr Qubuda, the lead clinician in this trial. “By using traditional healing plants that are known to Africans, and a specially treated plant extract, we have successfully shown HIV communities can improve their health and well-being”. Read below about the trial and the results that Asante Philani supported in the Cape Flats area, in Cape Town.

“This is the first of many opportunities to promote health within a community that faces many life challenges”, says Dr Holmes, Clinical Director of the Asante Philani Group. “We did not set out to design a product to give a HIV –ve result. We designed a product to support and boost the individuals own immune system to fight disease, and we have done that.”

New Supplement For HIV Communities

Traditional Anti-RetroViral (ARV’s) drugs have been shown to prolong the lives of those infected with HIV and help prevent HIV cross infection. But throughout Africa less than 32% of 23.5 million HIV positive Africans have access to ARV’s.

In a study carried out by Asante Viral in Cape Flats in Cape Town, a mix of treated African plant extracts were trialed as a health supplement.

The data show’s Asante-Viral ‘Viro-Cleanse’ offers people who are not on ARV’s an alternative supplement that supports their health and well-being. In this study, 72% showed decreased viral loading and increased ‘T’ and CD4 cell counts – in just 30-days.

Participants who were taking ARV’s have shown a 65% increase in CD4 and T-Cell counts. 93% of subjects reported feeling more energized, 96% felt more positive about their health and future, and no subject dropped out due to side effects. Those taking ARV’s showed no interactions with the supplements.

This is in stark comparison with ARV treatment where up to 98% report unwanted side-effects. ARVs have known serious side effects, including damage to the immune system and an increased risk of heart attacks in up to 90% of subjects.

“This is the first of many opportunities to promote health within a community that faces many life challenges”, says Dr Holmes, Clinical Director of the Asante Philani Group.

“These are outstanding results’ says CEO Venetia Kruger, who has been involved in the health business for many years. “We are now looking at other chronic illnesses where we can offer products for health and increased well-being that allow people to heal”.

‘Viro-Cleanse’ has uses for bacterial, fungal and viral infections, such as the ‘Super-Bugs’ and Herpes.

The products that are formulated into ‘Viro-Cleanse’ are grown in Africa, processed in Africa, and provide agricultural and processing opportunities for African co-operatives, rural communities and individuals to help themselves. The plant products used in ‘Viro-Cleanse’ are currently used by African Natural Healers. This study has illustrated where there is restricted access to conventional ARV treatment, which comes at a high financial cost to most African countries, traditional plant remedies have a place in treating sick people, especially those with HIV. Asante Viral has designed a product to support and boost the individuals own immune system to fight disease & improve health.